# Shanghai Hutchison Pharmaceuticals Limited

Organization · id `cardio:org-shanghai-hutchison-pharmaceuticals-limited` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Shanghai+Hutchison+Pharmaceuticals+Limited>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 6 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Shanghai Hutchison Pharmaceuticals Limited
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: A Trial to Evaluate Efficacy of Heart-protecting Musk Pill (`cardio:ct-nct01897805`)
- Sponsors: Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization (`cardio:ct-nct03072121`)
- Sponsors: Efficacy and Safety of Shexiang Baoxin Pill in Patients With Ischemia With Non-Obstructive Coronary Artery (`cardio:ct-nct04897126`)
- Sponsors: Evaluate the Efficacy and Safety of MUSK Pill on Coronary Microvascular Dysfunction (`cardio:ct-nct04984954`)
- Sponsors: Safety and Efficacy of SHPL-49 Injection in Participants With Acute Ischemic Stroke (`cardio:ct-nct06202378`)
- Sponsors: Phase III Clinical Trial of SHPL-49 Injection in the Treatment of Acute Ischemic Stroke (`cardio:ct-nct07241520`)

## Provenance

Content hash: f27a5873588fdc1741fd7d1ef20bd074d9e268a192d73ff439341cf785694926
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
